Research Topics
| Gavin J BlakeSummaryAffiliation: Mater Misericordiae Hospital Country: Ireland Publications
| Collaborators
|
Detail Information
Publications
Blood pressure, C-reactive protein, and risk of future cardiovascular eventsGavin J Blake
Center for Cardiovascular Disease Prevention and the Donald W Reynolds Center for Cardiovascular Research, Boston, Mass, USA
Circulation 108:2993-9. 2003..Accumulating data suggest a link between blood pressure and vascular inflammation...- C-reactive protein and the risk of developing hypertensionHoward D Sesso
Department of Medicine, Center for Cardiovascular Disease Prevention and the Division of Preventive Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Mass 02215 1204, USA
JAMA 290:2945-51. 2003..Although it has been hypothesized that hypertension is in part an inflammatory disorder, clinical data linking inflammation with incident hypertension are scarce... - Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemiaGavin J Blake
Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Am J Med 114:485-94. 2003.... - Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in womenGavin J Blake
Center for Cardiovascular Disease Prevention, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02215, USA
Circulation 106:1930-7. 2002..However, the magnitude of predictive value of LDL particle concentration (NMR) was not substantively different from that of the total cholesterol to HDL cholesterol ratio and was less than that of C-reactive protein... - Hemoglobin A1c level and future cardiovascular events among womenGavin J Blake
Cardiovascular Division, The Center for Cardiovascular Disease Prevention, and the Division of Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass, USA
Arch Intern Med 164:757-61. 2004..We sought to test this hypothesis prospectively in a cohort of women without overt cardiovascular disease... - Inflammatory biomarkers of the patient with myocardial insufficiencyGavin J Blake
Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Curr Opin Crit Care 9:369-74. 2003..Furthermore, the predictive value of inflammatory markers is independent of traditional risk markers such as lipid levels, or cardiac troponin levels among those with acute coronary syndromes... - C-reactive protein: a surrogate risk marker or mediator of atherothrombosis?Gavin J Blake
Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, 900 Commonwealth Ave. East, Boston, MA 02215, USA
Am J Physiol Regul Integr Comp Physiol 285:R1250-2. 2003 - Postinfarction ventricular septal defect with pseudoaneurysm repair after failed percutaneous closureSubroto Paul
Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA
Ann Thorac Surg 79:701-3. 2005..This case illustrates the importance of collaboration between interventional cardiologists and cardiac surgeons in the treatment of complex postinfarction ventricular septal defects... - Soluble CD40 ligand levels indicate lipid accumulation in carotid atheroma: an in vivo study with high-resolution MRIGavin J Blake
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA
Arterioscler Thromb Vasc Biol 23:e11-4. 2003.... - C-reactive protein and other inflammatory risk markers in acute coronary syndromesGavin J Blake
Center for Cardiovascular Disease Prevention, the Leducq Center for Cardiovascular Research, and the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
J Am Coll Cardiol 41:37S-42S. 2003..Furthermore, the benefits of lifestyle modification and drug therapy with aspirin or statins may be most marked among those with elevated CRP levels... - Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo controlled trialGavin J Blake
Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Eur Heart J 24:1843-7. 2003..We sought to determine the effect of randomization to pravastatin therapy on LDL particle concentration-NMR, among a primary prevention population... - Projected life-expectancy gains with statin therapy for individuals with elevated C-reactive protein levelsGavin J Blake
Center for Cardiovascular Disease Prevention, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
J Am Coll Cardiol 40:49-55. 2002..This analysis supports a crucial need for direct intervention trials aimed at subjects with elevated CRP levels... - Rescue percutaneous coronary intervention following coronary artery bypass graft--a descriptive analysis of the changing interface between interventional cardiologist and cardiac surgeonMark R Adams
Department of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA
Clin Cardiol 25:280-6. 2002.... - C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular eventsGavin J Blake
Arterioscler Thromb Vasc Biol 22:1512-3. 2002 - Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatmentMarc S Sabatine
TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital, Boston, Mass 02115
Circulation 111:1217-24. 2005..Whether the disparate outcomes exist independently of potential biases in treatment patterns remains unclear... - Long-term follow-up of the West of Scotland Coronary Prevention StudyJohn W McEvoy
N Engl J Med 358:193; author reply 194-5. 2008